CHICAGO — The odds of having gastric and pancreatic cancers were higher among postmenopausal women on hormone replacement therapy and remained significant after controlling for risk factors, according to data at Digestive Disease Week.“In the United States, approximately 40% of postmenopausal women use hormone replacement therapy (HRT) — estrogen with or without